See also this year's filing and all EDGAR filings for this company.
PDF Report 0001176309_2022_ORAMED_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001176309, ORAMED PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 95,337,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 397,000 |
| 3 | remainder_Assets | 32,265,000 |
| 4 | LiabilitiesCurrent | 6,679,000 |
| 5 | LiabilitiesNoncurrent | 4,803,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,937,000 |
| 9 | ResearchAndDevelopmentExpense | 20,989,000 |
| 10 | remainder_Expenses | 8,000 |
| 11 | remainder_Revenues | 2,703,000 |
| 12 | remainder_NetIncome | 1,242,000 |
| 13 | remainder_ComprehensiveNetIncome | 45,227,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 127,999,000 |
| 1 | Liabilities | 11,482,000 |
| 2 | Expenses | 26,934,000 |
| 3 | Revenues | 2,703,000 |
| 4 | StockholdersEquity | 116,517,000 |
| 5 | NetIncome | -22,989,000 |
| 6 | ComprehensiveNetIncome | -375,500 |
| 7 | BaseVar | 107,793,500 |
| 8 | EconomicCapitalRatio | 2.87 |
Edgar->Model Mapping
Feature Distribution
Change over Time
